Germany Post-Traumatic Stress Disorder (PTSD) Market - Industry Trends and Forecast to 2030

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $3,500	133 Pages	Data Bridge Market Research	November, 2022	DAABD17583182

Best Price Guarantee
Price	from $3,500
Length	133 Pages
Publisher	Data Bridge Market Research
Published Date	November, 2022
SKU	DAABD17583182

Germany Post-Traumatic Stress Disorder (PTSD) Market - Industry Trends and Forecast to 2030

The Germany Post-Traumatic Stress Disorder (PTSD) market is projected to register a substantial CAGR of 4.4% in the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2023 to 2030.

Market Segmentation

Germany Post-Traumatic Stress Disorder (PTSD) Market, By Type (Medication (antidepressant, antipsychotics), Psychotherapy, Software Devices), Route of Administration (Oral, Parenteral, and Others), Age Group (Children, Adults, Geriatric), End User (Hospitals, Outpatient Clinics, Mental Health Centers, Home HealthCare and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, and Others), Country (Germany) Industry Trends and Forecast to 2030
Some of the major factors contributing to the growth of Germany Post-Traumatic Stress Disorder (PTSD) Market are:
• Rising prevalence of PTSD
• Technological advancements in the diagnosis and treatment of PTSD

Market Players

Some of the major players operating in the Germany Post-Traumatic Stress Disorder (PTSD) Market are:
• AbbVie Inc.
• Viatris Inc
• Pfizer Inc.
• Eli Lilly and Company
• Takeda Pharmaceutical Company Limited
• Aurobindo Pharma.
• AstraZeneca
• Cipla Inc.
• Lupin
• Accord Healthcare GmbH
• Dr. Reddy’s Laboratories Ltd.
• Zydus Pharmaceuticals, Inc.
• GlaxoSmithKline Group of Companies.
• Teva Pharmaceutical Industries Ltd.
• Alkermes.
• Novartis AG., among others.

1 Introduction: 1.1 Objectives Of The Study; 1.2 Market Definition; 1.3 Overview Of The Germany Post-traumatic Stress Disorder (Ptsd) Market; 1.4 Currency And Pricing; 1.5 Limitations; 1.6 Markets Covered
2 Market Segmentation: 2.1 Markets Covered; 2.2 Geographical Scope; 2.3 Years Considered For The Study; 2.4 Dbmr Tripod Data Validation Model; 2.5 Primary Interviews With Key Opinion Leaders; 2.6 Multivariate Modelling; 2.7 Type Lifeline Curve; 2.8 Market Application Coverage Grid; 2.9 Dbmr Market Position Grid; 2.10 Vendor Share Analysis; 2.11 Secondary Sources; 2.12 Assumptions
3 Executive Summary: 3.1 Mergers And Acquisition; 3.2 Pipeline Analysis For Germany Post-traumatic Stress Disorder Market; 3.2.1 Recent Approvals; 3.3 Pestel Analysis; 3.4 Porter's Five Forces Model
4 Regulations Of Germany Post-traumatic Stress Disorder (Ptsd) Market: 4.1 Regulatory And Drug Approval Scenario In Germany; 4.2 Approval Framework; 4.2.1 Clinical Practice; 4.2.2 Marketing Authorization
5 Industry Insights: 5.1 Patent Analysis; 5.1.1 Drug Treatment Rate By Matured Markets; 5.1.2 Demographic Trends: Impacts On All Incidence Rate; 5.1.3 Key Pricing Strategies; 5.1.4 Key Patient Enrollment Strategies
6 Epidemiology: 6.1 Historic Ptsd Pool; 6.2 Present Ptsd Pool; 6.3 Furure Ptsd Pool; 6.4 Prevalence Of Dissociative Ptsd By Country; 6.5 Prevalence Of Uncomplicated Ptsd By Country; 6.6 Prevalence Of Comorbid Ptsd By Country; 6.7 Treatment Rate
7 Introduction: 7.1 Overview; 7.2 Impact Of Ukraine And Russia War On Germany Post-traumatic Stress Disorder (Ptsd) Market; 7.3 Impact Analysis On Demand; 7.4 Conclusion
8 Market Overview: 8.1 Drivers; 8.1.1 Rising Prevalence Of Ptsd.; 8.1.2 Technological Advancements In The Diagnosis And Treatment Of Ptsd.; 8.1.3 The Increasing Incidence Of Ptsd; 8.1.4 Increased Awareness Among Patients And Doctors Regarding Therapies For Ptsd; 8.2 Restraints; 8.2.1 High Cost Of The Treatment; 8.2.2 Side Effects Associated With Ptsd Treatment.; 8.3 Opportunities; 8.3.1 Rising Healthcare Expenditure; 8.3.2 Rising Approvals Of Drugs; 8.3.3 The Rising Number Of Clinical Trials Is Expected To Boost The Growth Of The Post-traumatic Stress Disorder Treatment Market; 8.4 Challenges; 8.4.1 Patent Expiry Of Drugs; 8.4.2 Rising Alternative Therapies; 8.5 Unmeet Needs; 8.5.1 Unmeet Reimbursement Cost; 8.5.2 Mental Health Status And Social Conditions Of Asylum Seekers
9 Germany Post-traumatic Stress Disorder (Ptsd) Market, By Type: 9.1 Overview; 9.2 Uncomplicated Ptsd; 9.3 Dissociative Ptsd; 9.4 Comorbid Ptsd; 9.5 Others
10 Germany Post-traumatic Stress Disorder (Ptsd) Market, By Treatment: 10.1 Overview; 10.2 Psychotherapy; 10.2.1 Cognitive Behavioral Therapy; 10.2.2 Family Therapy; 10.2.3 Stress Inoculation Therapy; 10.2.4 Prolonged Exposure Therapy; 10.2.5 Others; 10.3 Medication; 10.3.1 Antidepressants; 10.3.1.1 Selective Serotonin Reuptake Inhibitors; 10.3.1.1.1 Sertraline; 10.3.1.1.2 Paroxetine; 10.3.1.1.3 Fluoxetine; 10.3.1.1.4 Citalopram; 10.3.1.1.5 Nefazodone; 10.3.1.1.6 Others; 10.3.1.2 Serotonin-norepinephrine Reuptake Inhibitors; 10.3.1.2.1 Duloxetine; 10.3.1.2.2 Venlafaxine; 10.3.1.2.3 Others; 10.3.1.3 Tricyclic Antidepressants; 10.3.1.3.1 Amitriptyline; 10.3.1.3.2 Imipramine; 10.3.1.3.3 Others; 10.3.2 Antipsychotics; 10.3.2.1 Quetiapine; 10.3.2.2 Aripiprazole; 10.3.2.3 Divalproex; 10.3.2.4 Lamotrigine; 10.3.2.5 Others; 10.3.3 Others; 10.4 Software Devices; 10.4.1 Ptsd Coach; 10.4.2 Pe Coach; 10.4.3 Cpt Coach; 10.4.4 Others
11 Germany Post-traumatic Stress Disorder (Ptsd) Market , By Route Of Administration: 11.1 Overview; 11.2 Oral; 11.3 Parenteral; 11.4 Others
12 Germany Post-traumatic Stress Disorder (Ptsd) Market, By Age Group: 12.1 Overview; 12.2 Adults; 12.3 Geriatrics; 12.4 Children
13 Germany Post-traumatic Stress Disorder (Ptsd) Market, By End User: 13.1 Overview; 13.2 Mental Health Centers; 13.3 Hospitals; 13.4 Outpatient Clinics; 13.5 Home Healthcare; 13.6 Others
14 Germany Post-traumatic Stress Disorder (Ptsd) Market, By Distribution Channel: 14.1 Overview; 14.2 Hospital Pharmacy; 14.3 Retail Pharmacy; 14.4 Online Pharmacy; 14.5 Others
15 Germany Post-traumatic Stress Disorder (Ptsd) Market: Company Landscape: 15.1 Company Share Analysis: Germany
16 Swot Analysis
17 Company Profile: 17.1 Abbvie (2022); 17.1.1 Company Snapshot; 17.1.2 Revenue Analysis; 17.1.3 Product Portfolio; 17.1.4 Recent Development; 17.2 Viatris Inc. (2022); 17.2.1 Company Snapshot; 17.2.2 Revenue Analysis; 17.2.3 Product Portfolio; 17.3 Pfizer Inc; 17.3.1 Company Snapshot; 17.3.2 Revenue Analysis; 17.3.3 Product Portfolio; 17.3.4 Recent Developments; 17.3.5 Recent Development; 17.4 Eli Lilly And Company (2022); 17.4.1 Company Snapshot; 17.4.2 Revenue Analysis; 17.4.3 Product Portfolio; 17.4.4 Recent Development; 17.5 Takeda Pharmaceutical Company Limited (2022); 17.5.1 Company Snapshot; 17.5.2 Revenue Analysis; 17.5.3 Product Portfolio; 17.5.4 Recent Development; 17.6 Accord Healthcare Gmbh.; 17.6.1 Company Snapshot; 17.6.2 Product Portfolio; 17.6.3 Recent Developments; 17.7 Alkermes.; 17.7.1 Company Snapshot; 17.7.2 Revenue Analysis; 17.7.3 Product Portfolio; 17.7.4 Recent Developments; 17.8 Astrazeneca (2022); 17.8.1 Company Snapshot; 17.8.2 Revenue Analysis; 17.8.3 Product Portfolio; 17.8.4 Recent Development; 17.9 Aurobindo Pharma.; 17.9.1 Company Snapshot; 17.9.2 Revenue Analysis; 17.9.3 Product Portfolio; 17.9.4 Recent Developments; 17.10 Cipla Inc. (2022); 17.10.1 Company Snapshot; 17.10.2 Revenue Analysis; 17.10.3 Product Portfolio; 17.10.4 Recent Development; 17.11 Dr. Reddy's Laboratories Ltd; 17.11.1 Company Snapshot; 17.11.2 Revenue Analysis; 17.11.3 Product Portfolio; 17.11.4 Recent Developments; 17.12 Glaxosmithkline Group Of Companies.; 17.12.1 Company Snapshot; 17.12.2 Revenue Analysis; 17.12.3 Product Portfolio; 17.12.4 Recent Developments; 17.13 Lupin (2022); 17.13.1 Company Snapshot; 17.13.2 Revenue Analysis; 17.13.3 Product Portfolio; 17.13.4 Recent Development; 17.14 Novartis Ag; 17.14.1 Company Snapshot; 17.14.2 Revenue Analysis; 17.14.3 Product Portfolio; 17.14.4 Recent Developments; 17.15 Teva Pharmaceutical Industries Ltd.; 17.15.1 Company Snapshot; 17.15.2 Revenue Analysis; 17.15.3 Product Portfolio; 17.15.4 Recent Developments; 17.16 Zydus Pharmaceuticals, Inc. (2022); 17.16.1 Company Snapshot; 17.16.2 Revenue Analysis; 17.16.3 Product Portfolio; 17.16.4 Recent Development
18 Questionnaire
19 Related Reports 133
List Of Tables: Table 1 Germany Post-traumatic Stress Disorder (Ptsd) Market, By Type, 2021-2030 (Usd Million); Table 2 Germany Post-traumatic Stress Disorder (Ptsd) Market, By Treatment, 2021-2030 (Usd Million); Table 3 Germany Psychotherapy In Post-traumatic Stress Disorder (Ptsd) Market, By Treatment, 2021-2030 (Usd Million); Table 4 Germany Medication In Post-traumatic Stress Disorder (Ptsd) Market, By Treatment, 2021-2030 (Usd Million); Table 5 Germany Antidepressants In Post-traumatic Stress Disorder (Ptsd) Market, By Treatment, 2021-2030 (Usd Million); Table 6 Germany Selective Serotonin Reuptake Inhibitors In Post-traumatic Stress Disorder (Ptsd) Market, By Treatment, 2021-2030 (Usd Million); Table 7 Germany Serotonin-norepinephrine Reuptake Inhibitors In Post-traumatic Stress Disorder (Ptsd) Market, By Treatment, 2021-2030 (Usd Million); Table 8 Germany Tricyclic Antidepressants In Post-traumatic Stress Disorder (Ptsd) Market, By Treatment, 2021-2030 (Usd Million); Table 9 Germany Antipsychotics In Post-traumatic Stress Disorder (Ptsd) Market, By Treatment, 2021-2030 (Usd Million); Table 10 Germany Software Devices In Post-traumatic Stress Disorder (Ptsd) Market, By Treatment, 2021-2030 (Usd Million); Table 11 Germany Post-traumatic Stress Disorder (Ptsd) Market, By Route Of Administration, 2021-2030 (Usd Million); Table 12 Germany Post-traumatic Stress Disorder (Ptsd) Market, By Age Group, 2021-2030 (Usd Million); Table 13 Germany Post-traumatic Stress Disorder (Ptsd) Market, By End User, 2021-2030 (Usd Million); Table 14 Germany Post-traumatic Stress Disorder (Ptsd) Market, By Distribution Channel, 2021-2030 (Usd Million) 94
List Of Figures: Figure 1 Germany Post-traumatic Stress Disorder (Ptsd) Market : Segmentation; Figure 2 Germany Post-traumatic Stress Disorder (Ptsd) Market : Data Triangulation; Figure 3 Germany Post-traumatic Stress Disorder (Ptsd) Market : Droc Analysis; Figure 4 Germany Post-traumatic Stress Disorder (Ptsd) Market : Global Vs Regional Market Analysis; Figure 5 Germany Post-traumatic Stress Disorder (Ptsd) Market : Company Research Analysis; Figure 6 Germany Post-traumatic Stress Disorder (Ptsd) Market : Interview Demographics; Figure 7 Germany Post-traumatic Stress Disorder (Ptsd) Market : Market Application Coverage Grid; Figure 8 Germany Post-traumatic Stress Disorder (Ptsd) Market : Dbmr Market Position Grid; Figure 9 Germany Post-traumatic Stress Disorder (Ptsd) Market : Vendor Share Analysis; Figure 10 Germany Post-traumatic Stress Disorder (Ptsd) Market : Segmentation; Figure 11 Increasing Prevalence Of Post-traumatic Stress Disorder In Population Are Expected To Drive The Germany Post-traumatic Stress Disorder (Ptsd) Market In The Forecast Period; Figure 12 Uncoplicated Ptsd Segment Is Expected To Account For The Largest Share Of The Germany Post-traumatic Stress Disorder (Ptsd) Market In 2023 & 2030; Figure 13 Drivers, Restraints, Opportunities And Challenges Of Germany Post-traumatic Stress Disorder (Ptsd) Market; Figure 14 Germany Post-traumatic Stress Disorder (Ptsd) Market: By Type, 2022; Figure 15 Germany Post-traumatic Stress Disorder (Ptsd) Market: By Type, 2023-2030 (Usd Million); Figure 16 Germany Post-traumatic Stress Disorder (Ptsd) Market: By Type, Cagr (2023-2030); Figure 17 Germany Post-traumatic Stress Disorder (Ptsd) Market: By Type, Lifeline Curve; Figure 18 Germany Post-traumatic Stress Disorder (Ptsd) Market: By Treatment, 2022; Figure 19 Germany Post-traumatic Stress Disorder (Ptsd) Market: By Treatment, 2023-2030 (Usd Million); Figure 20 Germany Post-traumatic Stress Disorder (Ptsd) Market: By Treatment, Cagr (2023-2030); Figure 21 Germany Post-traumatic Stress Disorder (Ptsd) Market: By Treatment, Lifeline Curve; Figure 22 Germany Post-traumatic Stress Disorder (Ptsd) Market: By Route Of Administration, 2022; Figure 23 Germany Post-traumatic Stress Disorder (Ptsd) Market: By Route Of Administration, 2023-2030 (Usd Million); Figure 24 Germany Post-traumatic Stress Disorder (Ptsd) Market: By Route Of Administration, Cagr (2023-2030); Figure 25 Germany Post-traumatic Stress Disorder (Ptsd) Market: By Route Of Administration, Lifeline Curve; Figure 26 Germany Post-traumatic Stress Disorder (Ptsd) Market: By Age Group, 2022; Figure 27 Germany Post-traumatic Stress Disorder (Ptsd) Market: By Age Group, 2023-2030 (Usd Million); Figure 28 Germany Post-traumatic Stress Disorder (Ptsd) Market: By Age Group, Cagr (2023-2030); Figure 29 Germany Post-traumatic Stress Disorder (Ptsd) Market: By Age Group, Lifeline Curve; Figure 30 Germany Post-traumatic Stress Disorder (Ptsd) Market: By End User, 2022; Figure 31 Germany Post-traumatic Stress Disorder (Ptsd) Market: By End User, 2023-2030 (Usd Million); Figure 32 Germany Post-traumatic Stress Disorder (Ptsd) Market: By End User, Cagr (2023-2030); Figure 33 Germany Post-traumatic Stress Disorder (Ptsd) Market: By End User, Lifeline Curve; Figure 34 Germany Post-traumatic Stress Disorder (Ptsd) Market: By Distribution Channel, 2022; Figure 35 Germany Post-traumatic Stress Disorder (Ptsd) Market: By Distribution Channel, 2023-2030 (Usd Million); Figure 36 Germany Post-traumatic Stress Disorder (Ptsd) Market: By Distribution Channel, Cagr (2023-2030); Figure 37 Germany Post-traumatic Stress Disorder (Ptsd) Market: By Distribution Channel, Lifeline Curve; Figure 38 Germany Post-traumatic Stress Disorder (Ptsd) Market: Company Share 2022 (%) 97